J&J faulty hip implant victims meet expert committee, discuss compensation

Image
IANS New Delhi
Last Updated : Jan 09 2019 | 10:55 PM IST

Around 40 patients affected by alleged faulty Articular Surface Replacement (ASR) hip implants of Johnosn and Johnson met the five-member Central Expert Committee (CEC) on Wednesday to help formulate a compensation mechanism.

The Hip Implant Patients Support Group (HIPS), which is a support group for patients across India who have been implanted with faulty hip implants such as DePuy/JandJ ASR resurfacing and ASR XL implants, had been repeatedly writing to the Health and Welfare Ministry asking them to hold a meeting related to a compensation formula.

"This was the first time patients were meeting the CEC. The group presented its views about various deficiencies that we felt and recommended those have been missing in the Committee's suggestion," Renu Seth, victim, said during a media briefing held here.

Vijay Vojhala, one of the victims said that among the recommendations made by the HIPS, major focus was on the compensation amount along with other demands such as the J&J should continue to provide with reimbursement including medical management.

"We all have undergone different surgeries. We have a wide range of issues which have been placed and aiming for international standard of compensation from Johnson and Johnson. The CEC said that they are open to revisiting the compensation considering our recommendations as well," Vojhala said.

In August 2018, the report of the Agarwal Committee set up by the government was released which recommended compensation for ASR hip implant victims. Subsequently, the CEC headed by Dr. R.K. Arya was convened in October 2018 to start the compensation process.

The compensation formula recently approved by the government was met with serious concerns from patients as it had many deficiencies, exclusions and lacunae. The patients placed shared their views regarding the compensation formula, the process and related issues at this much delayed meeting with the Central Expert Committee.

On November 2018, the health ministry approved a formula for determining compensation for those who had received faulty ASR hip implants manufactured by DePuy Johnson and Johnson prior to August, 2010 will be eligible for the compensation.

However, the victims rejected the compensation rolled out by Centre stating that despite repeated requests, not a single consultation had taken place regarding the compensation process or the formula for determining the quantum of compensation with affected patients.

--IANS

som/prs

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 09 2019 | 10:44 PM IST

Next Story